These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32610896)

  • 1. Prodrug-Based Nanoreactors with Tumor-Specific
    Ren C; Liu H; Lv F; Zhao W; Gao S; Yang X; Jin Y; Tan Y; Zhang J; Liang XJ; Li Z
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34667-34677. PubMed ID: 32610896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity.
    Zhang B; Wan S; Peng X; Zhao M; Li S; Pu Y; He B
    J Mater Chem B; 2020 May; 8(17):3939-3948. PubMed ID: 32236239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer Prodrug-Based Nanoreactors Activated by Tumor Acidity for Orchestrated Oxidation/Chemotherapy.
    Li J; Li Y; Wang Y; Ke W; Chen W; Wang W; Ge Z
    Nano Lett; 2017 Nov; 17(11):6983-6990. PubMed ID: 28977746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
    Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z
    J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A self-assembled pH/enzyme dual-responsive prodrug with PEG deshielding for multidrug-resistant tumor therapy.
    Ni R; Zhu J; Xu Z; Chen Y
    J Mater Chem B; 2020 Feb; 8(6):1290-1301. PubMed ID: 31967176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation.
    Miller MA; Mikula H; Luthria G; Li R; Kronister S; Prytyskach M; Kohler RH; Mitchison T; Weissleder R
    ACS Nano; 2018 Dec; 12(12):12814-12826. PubMed ID: 30550257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting Oxidative Stress in Cancer Starvation Therapy by Site-Specific Startup of Hyaluronic Acid-Enveloped Dual-Catalytic Nanoreactors.
    Yao Z; Zhang B; Liang T; Ding J; Min Q; Zhu JJ
    ACS Appl Mater Interfaces; 2019 May; 11(21):18995-19005. PubMed ID: 31058483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pd@Pt-GOx/HA as a Novel Enzymatic Cascade Nanoreactor for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy.
    Ming J; Zhu T; Yang W; Shi Y; Huang D; Li J; Xiang S; Wang J; Chen X; Zheng N
    ACS Appl Mater Interfaces; 2020 Nov; 12(46):51249-51262. PubMed ID: 33161703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
    Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
    Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy.
    Tong F; Ye Y; Chen B; Gao J; Liu L; Ou J; van Hest JCM; Liu S; Peng F; Tu Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34630-34642. PubMed ID: 32635715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmable Therapeutic Nanodevices with Circular Amplification of H
    Li J; Wei Z; Lin X; Zheng D; Wu M; Liu X; Liu J
    Adv Healthc Mater; 2019 May; 8(10):e1801627. PubMed ID: 30945472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
    J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Polymersome Nanoreactors with Tumor-Specific Activable Cascade Reactions for Cooperative Cancer Therapy.
    Ke W; Li J; Mohammed F; Wang Y; Tou K; Liu X; Wen P; Kinoh H; Anraku Y; Chen H; Kataoka K; Ge Z
    ACS Nano; 2019 Feb; 13(2):2357-2369. PubMed ID: 30699292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side Effects.
    Yao M; Ma X; Zhang X; Shi L; Liu T; Liang X; Zhao H; Li X; Li L; Gao H; Jia B; Wang F
    Theranostics; 2019; 9(3):747-760. PubMed ID: 30809306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH/Reduction Dual-Triggered Degradable Poly(doxorubicin) Prodrug Nanoparticles for Leakage-Free Tumor-Specific Self-Delivery.
    Li J; Liu P
    Macromol Rapid Commun; 2018 Sep; 39(18):e1800381. PubMed ID: 30073742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery.
    Song H; Zhang J; Wang W; Huang P; Zhang Y; Liu J; Li C; Kong D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():365-74. PubMed ID: 26433349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid-active supramolecular anticancer nanoparticles based on cyclodextrin polyrotaxanes damaging both mitochondria and nuclei of tumor cells.
    Bai S; Zhang X; Ma X; Chen J; Chen Q; Shi X; Hou M; Xue P; Kang Y; Xu Z
    Biomater Sci; 2018 Nov; 6(12):3126-3138. PubMed ID: 30362476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression.
    Hang L; Zhang T; Wen H; Li M; Liang L; Tang X; Zhou C; Tian J; Ma X; Jiang G
    Theranostics; 2021; 11(20):10001-10011. PubMed ID: 34815800
    [No Abstract]   [Full Text] [Related]  

  • 20. A cationic prodrug/therapeutic gene nanocomplex for the synergistic treatment of tumors.
    Lu X; Wang QQ; Xu FJ; Tang GP; Yang WT
    Biomaterials; 2011 Jul; 32(21):4849-56. PubMed ID: 21458064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.